 Zee News [1] |
Lupin Settles Patent Dispute Over Glumetza Diabetes Treatment [2]
Fox Business BY) Thursday said it has settled a patent infringement litigation with Santarus Inc. (SNTS) and DepoMed Inc. (DEPO) over the Glumetza extended-release tablets for diabetes treatment [3]. The settlement allows Lupin to sell a generic version of Glumetza … Santarus and Depomed Announce Settlement with Lupin of GLUMETZA Patent Litigation [4]MarketWatch (press release) all 24 news articles » [5] |
More details can be found at www.diabeteshowto.com [6]